Theranexus is a biopharmaceutical company that develops and commercializes drug candidates for the treatment of central nervous system disorders.
Business Model:
Revenue: $0
Employees: 11-50
Address: 60, Avenue Rockefeller
City: Lyon
State: rhône alpes
Zip: 69008
Country: FR
Theranexus is a biopharmaceutical company that develops and commercializes drug candidates for the treatment of central nervous system disorders.
Contact Phone:
Contact Email:
Listed Exchange:
PA
IPO Date:
10/30/2017
IPO Valuation:
$55M
Ticker Symbol:
ALTHX
IPO Price:
$18.05952185376914/share
Amount Raised:
$23M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2020 | Debt | $3.8M |
Bpifrance |
11/2014 | Seed Round | 5 | $4.5M |
Auriga Partners CEA Investissement Rhone-Alpes Creation Sofimac Investment Managers Wilco Auriga Partners CEA Investissement Rhone-Alpes Creation Sofimac Investment Managers Wilco |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|